Cost Savings and Health Benefits Prompts Medicare Coverage of Influenza Vaccine
A four-year congressionally mandated demonstration project has demonstrated health and economic benefits of influenza vaccination and has prompted coverage for influenza vaccine for all Medicare beneficiaries. In the last year alone of the Medicare Influenza Vaccine Demonstration, overall influenza vaccination levels almost exceeded the national health objective for the year 2000 of 60% vaccine coverage among noninstitutionalized persons a65 years.
Case-control studies of vaccine effectiveness in preventing hospitalization for pneumonia were conducted during the demonstration. These studies estimated that influenza vaccine was 31% to 45% effective in preventing hospitalization for any pneumonia during the 1989-90, 1990-91, and 1991-92 
AIDS Rates Increases Are Greater Among Women
Reported AIDS cases among women in 1992 continued to increase at a faster rate than among men, and for the first time, more than half the cases among women were the result of heterosexual contact. From 1991 to 1992, the increase in reported cases among women was 9.8%, compared to 2.4% for men. Although the proportionate increase in cases attributed to heterosexual contact was greater for men than for women in 1992 (26.3% versus 11.5%), women accounted for a majority of the persons infected through heterosexual contact (59.4%). For the second consecutive year, the number of reported cases among homosexual/bisexual men decreased during 1992.
The CDC stated that "the steady increase in heterosexually acquired AIDS cases among men and women underscores the need to improve understanding of the factors that influence the adoption of safer sexual practices ... and how these factors vary in different population subgroups." The CDC also commented that because injecting drug users and men who have sex with men continue to account for 80.5% of the cases, prevention efforts targeting these populations must remain a priority and interventions targeting persons at increased risk for heterosexual transmission must be strengthened.
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